People

The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

 

Arthur Durazo, PhD

Postdoctoral Scholar
Medicine

Arthur (Arturo) Durazo is a health psychologist with an emphasis on behavioral medicine, eHealth/mHealth interventions, and health equity. His research focuses on psychosocial factors that promote protective behaviors among those with disproportionate burdens of illness associated with membership in low socioeconomic and ethnic minority groups.

Jennifer Fung, PhD

Assoc Professor In Residence
Ob/Gyn, Reproductive Sciences

Stuart Gansky, MS, DrPH

Professor
Preventive & Restor Dent Sci

My research concentrates on oral health research, health disparities research, applied statistical analyses and related method­ological issues. Balancing these components is essential to successful and practical oral epidemiology research. Methodological examination helps ground health research and build convincing argu­ments, while collaborative health research generates opportunities for innovative statistical practice and provides challenges for developing ways to solve real world problems

Peter Ganz

Chief, Cardiology/SFGH
Medicine

Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.

Stanton Glantz, PhD

Professor of Medicine
Medicine

RESEARCH INTERESTS: Dr. Glantz conducts research on a wide range of topics ranging from the health effects of e-cigarettes and secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include cannabis policy, because of the interactions between tobacco and cannabis.

Warren Gold, MD

Professor Emeritus
Medicine

Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.

Jeffrey Gotts, MD, PhD

Assistant Professor
Medicine

Research focuses on the effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery
Associate Vice Chancellor, Clinical and Translational Science Institute
Otolaryngology

Dr. Jennifer R. Grandis received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr. Grandis was the UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology and Chemical Biology at the University of Pittsburgh.

Lawrence Green, DrPH, MPH

Professor Emeritus
Epidemiology & Biostatistics

Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based. Dr. Green has been the PI on research grants and on predoctoral and postdoctoral training grants from NIH,, the VA , CDC, AHRQ, and the Canadian Institute for Health Research.

Joe Guydish, PhD

Professor
Institute for Health Policy Studies

Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence. Joseph Guydish, PhD, MPH, is Professor of Medicine and Health Policy at the University of California, San Francisco.   His research concerns access, delivery, and organization of substance abuse treatment services.

Amy Hafez, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Sharon Hall, PhD

Professor Emeritus
Psychiatry

Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations. Dr. Hall's research is on the treatment of drug abuse, especially tobacco dependence, and better understanding the processes of change through randomized clinical trials and related studies. She is especially interested in the treatment of comorbidities in special populations, and the complexities that comorbidities introduce into treatment.

Pages